Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: A meta-analysis

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 1, 2008, Pages 74-81

  Abdullah, Anwar K ^a,c   Khan, Salman ^b  

^a Virginia Center for Behavioral Rehabilitation   (United States)

^b Central State Hospital Virginia   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; MOMETASONE FUROATE; PLACEBO; TRIAMCINOLONE;

ARTICLE; ASTHMA; BIBLIOGRAPHIC DATABASE; CHRONIC DISEASE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESEARCH; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 47349116338     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60838-1     Document Type: Article

References (28)

1. Global Initiative for Asthma. GINA report: Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org. Accessed September 4, 2007.
2. Abdullah AK, Khan S. Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma. J Asthma. 2007;44:1-12.
3. Ververeli K, Chipps B. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. Ann Allergy Asthma Immunol. 2004;92:512-522.
4. Rafferty P, Tucker LG, Frame MH, Fergusson RJ, Biggs BA, Crompton GK. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. Br J Dis Chest. 1985;79:244-250.
5. Glenny AM, Altman DG, Song F, et al; International Stroke Trial Collaborative Group. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9:1-134, iii-iv.
6. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement: Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-1900.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
9. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326:219.
10. Bax L, Yu LM, Ikeda N, Tsuruta N, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50.
11. Cameron SJ, Cooper EJ, Crompton GK, Hoare MV, Grant IW. Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma. BMJ. 1973;4:205-207.
12. Hodson ME, Batten JC, Clarke SW, Gregg I. Beclomethasone dipropionate aerosol in asthma: transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis. 1974;110:403-408.
13. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma: preliminary report of the Brompton Hospital-Medical Research Council Collaborative Trial. Lancet. 1974;2:303-307.
14. Harvey LL, Nair SV, Kass I. Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthma: a 12-week double-blind study comparing beclomethasone dipropionate and a vehicle aerosol. Chest. 1976;70:345-350.
15. Kerigan AT, Pugsley SO, Cockcroft DW, Hargreave FE. Substitution of inhaled beclomethasone dipropionate for ingested prednisone in steroid-dependent asthmatics. Can Med Assoc J. 1977;116:867-871.
16. Richards W, Platzker A, Church JA, Yamamoto F, Foster S. Steroid-dependent asthma treated with inhaled beclomethasone dipropionate in children. Ann Allergy. 1978;41:274-277.
17. Lacronique J, Renon D, Georges D, Henry-Amar M, Marsac J. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur Respir J. 1991;4:807-812.
18. Nelson HS, Bernstein IL, Fink J, et al; Pulmicort Turbuhaler Study Group. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Chest. 1998;113:1264-1271.
19. Miyamoto T, Takahashi T, Nakajima S, et al; Japanese Pulmicort Turbuhaler study group. A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Respirology. 2000;5:231-240.
20. Bateman E, Karpel J, Casale T, Wenzel S, Banerji D. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma. Chest. 2006;129:1176-1187.
21. Slavin RG, Izu AE, Bernstein IL, et al. Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma. J Allergy Clin Immunol. 1980;66:379-385.
22. Shapiro GG, Izu AE, Furukawa CT, Pierson WE, Bierman CW. Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents. Chest. 1981;80:671-675.
23. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med. 1995;152(pt 1):1467-1473.
24. Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med. 1999;93:689-699.
25. Nelson HS, Busse WW, deBoisblanc BP, et al. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol. 1999;103(pt 1):267-275.
26. Fish JE, Karpel JP, Craig TJ, et al. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol. 2000;106:852-860.
27. Karpel JP, Nayak A, Lumry W, et al. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Respir Med. 2007;101:628-637.
28. Chervinsky P. Treatment of steroid-dependent asthma with triamcinolone acetonide aerosol. Ann Allergy. 1977;38:192-197.